Skip to contentI
Inspire Medical Systems, Inc.
I
INSPInspire Medical Systems, Inc. Q1 2025 · 10-Q
Revenue$201.32M$201.32M+22.7% vs Q1 2024 Net Income$2.99M$2.99MN/M vs Q1 2024 EPS Diluted$0.10$0.10N/M vs Q1 2024 Gross Profit$170,608,000+22.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inspire Medical Systems, Inc. · CIK 1609550 · Engraved from SEC EDGAR
Operating Cash Flow-$6,703,000N/M Free Cash Flowderived-$15,110,000N/M Margins · derivedGross margin84.7%−0.2 pt vs Q1 2024
Operating margin-0.7%+8.5 pt vs Q1 2024
Net margin1.5%+7.6 pt vs Q1 2024
ended Mar 31, 2025 · filed May 5, 2025 · 35 d after period end